TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Unimedic Pharma Holding AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 | 
| Turnover | 2,714 | 3,993 | 3,720 | 
| Financial expenses | 4,337 | 1,698 | 1,336 | 
| Earnings before taxes | -4,441 | -3,133 | -1,825 | 
| EBITDA | -547 | -1,553 | -524 | 
| Total assets | 81,375 | 81,243 | 76,177 | 
| Current assets | 348 | 3,124 | 1,163 | 
| Current liabilities | 6,048 | 7,592 | 12,462 | 
| Equity capital | 754 | 318 | 499 | 
| - share capital | 300   | 300   | 300 | 
| Employees (average) | 0   | 0   | 0 | 
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 | 
| Solvency | 0.9% | 0.4% | 0.7% | 
| Turnover per employee | |||
| Profit as a percentage of turnover | -163.6% | -78.5% | -49.1% | 
| Return on assets (ROA) | -0.1% | -1.8% | -0.6% | 
| Current ratio | 5.8% | 41.1% | 9.3% | 
| Return on equity (ROE) | -589.0% | -985.2% | -365.7% | 
| Change turnover | -1,279 | 273 | 888 | 
| Change turnover % | -32% | 7% | 31% | 
| Chg. No. of employees | 0   | 0 | -3 | 
| Chg. No. of employees % | -100% | 
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 | 
| Total value of public sale | 0   | 0   | 0 | 
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.
 
         
                    